Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
14q11 2 Microduplication Syndrome C4749855
A rare genetic condition involving a small extra piece of chromosome 14. Features vary and may include developmental delays. Management focuses on supportive therapies and monitoring.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a possible feature, with intellectual disability also reported. | May occur, but features and severity vary. | Low |
| Facial appearance | Distinctive facial features are described, without a fixed pattern established here. | No specific facial pattern is established in the supplied data. | Moderate |
| Overall severity | Source classification is severe. | Source classification is moderate, with variable expression. | Moderate |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Confirmed chromosome 21 deletion in the stated region
The diagnosis depends on the specific deleted locus, not clinical overlap.
High
Congenital presentation with developmental disability
Fits the supplied congenital onset and reported developmental features, but is not specific.
Low
Need for developmental support planning
Management is described as developmental support and medical monitoring.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
Confirmed extra material at 14q11.2
A duplication at this locus distinguishes it from a chromosome 21 deletion.
High
Variable developmental findings from birth to early childhood
Supplied onset spans early life and features are explicitly variable.
Moderate
Supportive-care planning without assuming severe disease
Source severity is moderate, but individual outcomes are not established.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion involving the stated chromosome 21 region. | May detect a small duplication at 14q11.2. | The locus and copy-number change are the main distinction; clinician review is required. |
| Karyotype | May miss a small deletion; no normal result excludes it. | May miss a small duplication; no normal result excludes it. | A normal karyotype does not establish or exclude either condition. |
| Targeted FISH or locus testing | Useful only if directed to the relevant chromosome 21 region. | Useful only if directed to 14q11.2. | A targeted test cannot assess the other syndrome unless that locus is included. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; developmental support is central.
- Factors
- Severity classification, confirmed deletion, and associated medical needs.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Outcome is variable and not established from the supplied description.
- Factors
- Duplication confirmation, developmental profile, and individual complications.
Time frame: Both are chronic congenital conditions; no reliable time course is supplied.
Genetic result, developmental progress, medical complications, and access to support.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Intellectual disability and developmental delay are described as possible. Developmental delay may occur, with variable severity. Neither complication is universal based on the supplied data. |
| Medical complexity | Severe classification suggests closer monitoring may be needed. Moderate classification does not exclude important individual needs. Exact organ complications and frequencies are not established here. |
| Family recurrence concern | Depends on whether a parental chromosomal rearrangement is found. Depends on parental testing and the specific duplication mechanism. Recurrence cannot be estimated without genetics evaluation. |
Patient education highlights
- HighGenetic confirmation
Clinical features overlap; the chromosomal result and specialist interpretation determine the diagnosis.
- HighSupportive care
Both conditions are managed with developmental therapies and individualized medical monitoring.
- MediumUncertainty
Available descriptions are sparse, so prognosis and complications should not be inferred from the label alone.